Archives

NeuroTherapia announces completion of its Phase 2a Trial of a novel treatment for Alzheimer’s Disease

B Trial Designed to Demonstrate Target Engagement, Safety, and Pharmacokinetics CLEVELAND, April 7, 2026 /PRNewswire/ — NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies… Login to continue reading Login…

Read MoreNeuroTherapia announces completion of its Phase 2a Trial of a novel treatment for Alzheimer’s Disease

AI Tokenized US Based Rare Earth Mineral Projects Vital to Technology from Smart Devices to Electric Vehicles and Defense Systems: MAG MAGNA CORP. (Stock Symbol: MGNC)

$MGNC Samples Show Some of the Highest REE Concentrations in North America Including Heavy Rare Earth Elements Creating Extremely High Value Ore Exploring Critical Strategic… Login to continue reading Login…

Read MoreAI Tokenized US Based Rare Earth Mineral Projects Vital to Technology from Smart Devices to Electric Vehicles and Defense Systems: MAG MAGNA CORP. (Stock Symbol: MGNC)